Find a Specialist by Postal Code | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Sung-Soo Yoon, MD, PhD, MS Seoul National University Hospital. Seoul Seoul Special City South Korea
Kohei Hosokawa, MD, PhD Kanazawa University Hospital Kanazawa Isikawa (Ishikawa) Japan
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Shinji Nakao, MD, PhD Japanese Red Cross Ishikawa Blood Center Kanazawa Isikawa (Ishikawa) Japan
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hiroyuki Takamori, MD Osaka Univesity Graduate School of Medicine Suita Osaka Japan
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hawk Kim, MD, PhD Gachon University Gil Medical Center Namdong-gu Incheon Metropolitan City South Korea
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
Hoon Kook, MD, PhD Chonnam National University Children's Hospital Gwangju Gwangju Metropolitan City South Korea
  • Aplastic Anemia
  • Pediatric
Marie Sebert, MD, PhD Hôpital Saint-Louis Paris Paris (75) France
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Gerard Socie, MD Hospital St. Louis Paris Paris (75) France
  • Aplastic Anemia
  • Graft Versus Host Disease (GVHD)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Regis Peffault de Latour, MD, PhD Hôpital Saint-Louis Paris Paris (75) France
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Manuel Espinoza Gutarra, MD University of Alabama Birmingham Birmingham Alabama United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Pankit Vachhani, MD University of Alabama Birmingham Birmingham Alabama United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jason Farrar, MD Arkansas Children’s Hospital Little Rock Arkansas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Krisstina Gowin, DO University of Arizona Tucson Arizona United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Jeffrey J. Pu, MD, PhD University of Arizona Cancer Center in Tuscon, Tuscon Arizona United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Yael Kusne, MD PhD Mayo Clinic, Phoenix, AZ Phoenix Arizona United States
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Cecilia Arana Yi, MD, MSHS, FACP Mayo Clinic, Phoenix, AZ Phoenix Arizona United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Jeanne M. Palmer, MD Mayo Clinic, Phoenix, AZ Phoenix Arizona United States
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Kirk R. Schultz, MD British Columbia Children’s Hospital Vancouver British Columbia Canada
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric
Joshua Sasine, MD, PhD Cedars-Sinai Los Angeles California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ramy M. Hanna, MD, FASN, FACP University of California Irvine Orange California United States
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)